ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
6,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
7,1,Headache,Headaches NEC,Headaches,Nerv,N
7,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
7,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
8,1,Headache,Headaches NEC,Headaches,Nerv,N
8,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9,1,Headache,Headaches NEC,Headaches,Nerv,N
9,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10,1,Headache,Headaches NEC,Headaches,Nerv,N
10,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
12,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
13,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
14,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
15,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
16,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
17,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
18,1,Headache,Headaches NEC,Headaches,Nerv,N
18,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
18,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
18,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
19,1,Headache,Headaches NEC,Headaches,Nerv,N
19,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
19,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
19,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
20,1,Headache,Headaches NEC,Headaches,Nerv,N
20,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
20,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
20,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
21,1,Headache,Headaches NEC,Headaches,Nerv,N
21,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
21,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
21,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
22,1,Headache,Headaches NEC,Headaches,Nerv,N
22,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
22,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
22,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
23,1,Headache,Headaches NEC,Headaches,Nerv,N
23,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
23,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
23,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
24,1,Headache,Headaches NEC,Headaches,Nerv,N
24,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
24,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
24,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
25,1,Headache,Headaches NEC,Headaches,Nerv,N
25,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
25,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
25,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
26,1,Headache,Headaches NEC,Headaches,Nerv,N
26,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
26,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
26,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
27,1,Headache,Headaches NEC,Headaches,Nerv,N
27,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
27,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
27,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
28,1,Headache,Headaches NEC,Headaches,Nerv,N
28,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
28,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
28,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,1,Headache,Headaches NEC,Headaches,Nerv,N
29,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
29,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
29,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
30,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
31,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
32,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
33,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
34,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
34,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
34,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
34,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
35,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
35,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
36,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
36,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
37,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
37,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
37,3,Right ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
37,4,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
38,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
38,2,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
38,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
38,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
39,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
39,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
39,3,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
40,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
41,2,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
41,3,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
42,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
42,2,Device dislocation,Device issues NEC,Device issues,Prod,N
42,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
43,1,Abdominal compartment syndrome,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
43,2,Propofol infusion syndrome,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
44,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
45,1,Device failure,Device issues NEC,Device issues,Prod,N
45,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
46,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
46,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
47,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
48,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
49,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
49,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
49,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
49,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
49,7,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
49,8,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
49,9,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
49,10,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
49,11,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
49,12,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
49,13,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
49,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
49,15,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
50,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
51,2,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
51,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
51,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
51,5,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
51,6,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
51,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
52,1,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
53,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
54,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
54,3,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
55,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
55,2,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
55,3,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
55,4,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
55,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
55,6,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
55,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
56,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
57,2,Base excess decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
57,3,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
57,4,Blood pH decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
57,5,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
57,6,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
57,7,Cardiac contractility decreased,Myocardial disorders NEC,Myocardial disorders,Card,N
57,8,Cardiac output decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
57,9,Decreased ventricular preload,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
57,10,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,11,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,12,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
57,13,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
57,14,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
57,15,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
57,16,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
57,17,Tryptase increased,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
58,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
58,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
58,3,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
59,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
60,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
61,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
62,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
63,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
64,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,2,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
65,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
65,2,Headache,Headaches NEC,Headaches,Nerv,N
65,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
66,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,3,Myocardial stunning,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
67,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
68,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
68,2,Dry gangrene,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
69,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
70,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
70,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
71,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
72,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
73,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
73,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
73,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
73,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
73,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
73,6,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
73,7,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
73,8,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
73,9,Product label confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
73,10,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
73,11,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
73,12,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
73,13,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
73,14,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
74,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
74,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
74,3,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
75,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
75,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
76,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
76,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
76,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
76,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
76,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
76,6,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
76,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
76,8,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
76,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
77,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
77,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
78,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
78,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
78,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
78,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
78,5,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
78,6,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
78,7,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
78,8,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,9,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
78,10,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
78,11,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
78,12,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
78,13,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
79,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
80,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
81,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
81,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
82,1,Brain herniation,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
82,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
82,3,Coma,Coma states,Neurological disorders NEC,Nerv,N
82,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
82,5,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
82,6,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
82,7,Reversible cerebral vasoconstriction syndrome,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
82,8,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
83,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
84,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
85,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
86,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
86,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
86,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
86,4,Gastric infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
86,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
87,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
87,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
87,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
87,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
87,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
88,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
88,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
88,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
88,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
88,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
89,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
89,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
89,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
89,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
89,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
89,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
90,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
91,2,Limb amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
92,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
92,2,Limb amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
93,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
94,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
94,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
94,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
95,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
97,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
97,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
98,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
100,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
101,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
101,2,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
102,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
104,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
104,3,Conduction disorder,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
104,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,5,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
104,6,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
104,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
104,8,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
104,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
105,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
105,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
105,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
106,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
106,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
106,3,Conduction disorder,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
106,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
106,5,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
106,6,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
106,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
106,8,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
107,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,2,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
108,1,Dry gangrene,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
109,1,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
110,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,2,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
111,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
111,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
112,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
112,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
112,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
113,1,Herpes simplex reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
113,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
113,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
113,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
114,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
114,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
115,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
116,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
117,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
